Head-To-Head Contrast: Schrödinger (NASDAQ:SDGR) vs. Guardion Health Sciences (NASDAQ:GHSI)

Guardion Health Sciences (NASDAQ:GHSI) and Schrödinger (NASDAQ:SDGR) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, institutional ownership and risk.

Valuation & Earnings

This table compares Guardion Health Sciences and Schrödinger’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardion Health Sciences	$12.25 million	1.03	$160,000.00	($4.02)	-2.46
Schrödinger	$216.67 million	7.51	$40.72 million	($1.88)	-11.91

Schrödinger has higher revenue and earnings than Guardion Health Sciences. Schrödinger is trading at a lower price-to-earnings ratio than Guardion Health Sciences, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Guardion Health Sciences has a beta of 0.91, suggesting that its share price is 9% less volatile than the S&P 500. Comparatively, Schrödinger has a beta of 1.51, suggesting that its share price is 51% more volatile than the S&P 500.

Profitability

This table compares Guardion Health Sciences and Schrödinger’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Guardion Health Sciences	-16.69%	-77.29%	-42.08%
Schrödinger	-75.94%	-29.25%	-20.60%

Insider and Institutional Ownership

20.2% of Guardion Health Sciences shares are owned by institutional investors. Comparatively, 79.1% of Schrödinger shares are owned by institutional investors. 1.3% of Guardion Health Sciences shares are owned by insiders. Comparatively, 8.6% of Schrödinger shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Guardion Health Sciences and Schrödinger, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardion Health Sciences	0	1	0	0	2.00
Schrödinger	0	3	7	1	2.82

Schrödinger has a consensus price target of $38.90, indicating a potential upside of 73.66%. Given Schrödinger’s stronger consensus rating and higher probable upside, analysts plainly believe Schrödinger is more favorable than Guardion Health Sciences.

Summary

Schrödinger beats Guardion Health Sciences on 13 of the 15 factors compared between the two stocks.

About Guardion Health Sciences

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

About Schrödinger

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.